$ 25.50 · 5 (99) · In stock
MD Anderson research shows modern chemotherapies are tied to a small but significant increased risk of secondary MDS and AML in older breast cancer patients. These findings may help oncologists understand their patients’ risks and better inform discussions with them.
Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics - ScienceDirect
Frontiers Long-Term Effects of Pediatric Acute Lymphoblastic Leukemia Chemotherapy: Can Recent Findings Inform Old Strategies?
Leukemia in Infants: Understanding This Rare Condition
Cancers, Free Full-Text
Leukemia: Symptoms, Signs, Causes, Types & Treatment
Study finds higher risk of rare blood cancer after chemo - NCI
Bone Marrow Transplant for Leukemia in Delhi, India
Cancer Risk By Age: What the Science Says
Blood Cancers Overview - History, Advancements and Challenges
Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®) - NCI